Medical - Healthcare Information Services
Compare Stocks
5 / 10Stock Comparison
NRC vs MORN vs MSCI vs SATS vs SPGI
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
Communication Equipment
Financial - Data & Stock Exchanges
NRC vs MORN vs MSCI vs SATS vs SPGI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges | Communication Equipment | Financial - Data & Stock Exchanges |
| Market Cap | $440M | $6.92B | $45.96B | $37.23B | $125.50B |
| Revenue (TTM) | $139M | $2.45B | $3.13B | $14.80B | $15.34B |
| Net Income (TTM) | $9M | $403M | $1.32B | $-23.27B | $4.78B |
| Gross Margin | 55.9% | 61.0% | 82.4% | 39.1% | 70.2% |
| Operating Margin | 14.1% | 21.5% | 54.7% | -116.5% | 42.2% |
| Forward P/E | 22.2x | 15.3x | 32.2x | — | 21.6x |
| Total Debt | $79M | $1.41B | $6.31B | $31.01B | $14.20B |
| Cash & Equiv. | $4M | $475M | $515M | $1.88B | $1.75B |
NRC vs MORN vs MSCI vs SATS vs SPGI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | May 26 | Return |
|---|---|---|---|
| National Research C… (NRC) | 100 | 33.6 | -66.4% |
| Morningstar, Inc. (MORN) | 100 | 129.1 | +29.1% |
| MSCI Inc. (MSCI) | 100 | 189.1 | +89.1% |
| EchoStar Corporation (SATS) | 100 | 462.1 | +362.1% |
| S&P Global Inc. (SPGI) | 100 | 128.7 | +28.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NRC vs MORN vs MSCI vs SATS vs SPGI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NRC ranks third and is worth considering specifically for dividends.
- 2.5% yield, 1-year raise streak, vs MORN's 1.0%, (1 stock pays no dividend)
MORN is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 12 yrs, beta 0.41, yield 1.0%
- Lower volatility, beta 0.41, current ratio 0.99x
- PEG 1.35 vs SPGI's 2.48
- Beta 0.41, yield 1.0%, current ratio 0.99x
MSCI carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 9.7%, EPS growth 10.7%
- 7.4% 10Y total return vs SATS's 222.7%
- 9.7% NII/revenue growth vs SATS's -5.2%
- 38.4% margin vs SATS's -157.2%
SATS is the clearest fit if your priority is momentum.
- +5.4% vs MORN's -40.5%
Among these 5 stocks, SPGI doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.7% NII/revenue growth vs SATS's -5.2% | |
| Value | Better valuation composite | |
| Quality / Margins | 38.4% margin vs SATS's -157.2% | |
| Stability / Safety | Beta 0.41 vs SATS's 1.72, lower leverage | |
| Dividends | 2.5% yield, 1-year raise streak, vs MORN's 1.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +5.4% vs MORN's -40.5% | |
| Efficiency (ROA) | 24.0% ROA vs SATS's -49.1%, ROIC 34.9% vs -32.9% |
NRC vs MORN vs MSCI vs SATS vs SPGI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NRC vs MORN vs MSCI vs SATS vs SPGI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSCI leads in 2 of 6 categories
MORN leads 1 • SATS leads 1 • NRC leads 0 • SPGI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSCI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SPGI is the larger business by revenue, generating $15.3B annually — 110.6x NRC's $139M. MSCI is the more profitable business, keeping 38.4% of every revenue dollar as net income compared to SATS's -157.2%. On growth, NRC holds the edge at +3.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $139M | $2.4B | $3.1B | $14.8B | $15.3B |
| EBITDAEarnings before interest/tax | $28M | $763M | $2.0B | -$16.0B | $7.8B |
| Net IncomeAfter-tax profit | $9M | $403M | $1.3B | -$23.3B | $4.8B |
| Free Cash FlowCash after capex | $17M | $437M | $1.5B | -$909M | $5.6B |
| Gross MarginGross profit ÷ Revenue | +55.9% | +61.0% | +82.4% | +39.1% | +70.2% |
| Operating MarginEBIT ÷ Revenue | +14.1% | +21.5% | +54.7% | -116.5% | +42.2% |
| Net MarginNet income ÷ Revenue | +6.5% | +15.3% | +38.4% | -157.2% | +29.2% |
| FCF MarginFCF ÷ Revenue | +12.6% | +18.1% | +49.4% | -6.1% | +35.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.7% | — | — | -5.2% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -44.0% | +50.0% | +49.1% | +28.2% | +32.5% |
Valuation Metrics
MORN leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 20.5x trailing earnings, MORN trades at a 49% valuation discount to MSCI's 40.6x P/E. Adjusting for growth (PEG ratio), MORN offers better value at 1.81x vs SPGI's 3.32x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $440M | $6.9B | $46.0B | $37.2B | $125.5B |
| Enterprise ValueMkt cap + debt − cash | $515M | $7.9B | $51.8B | $66.4B | $138.0B |
| Trailing P/EPrice ÷ TTM EPS | 37.56x | 20.52x | 40.58x | -2.56x | 28.92x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.19x | 15.30x | 32.17x | — | 21.61x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.81x | 2.40x | — | 3.32x |
| EV / EBITDAEnterprise value multiple | 17.05x | 10.96x | 26.79x | — | 18.02x |
| Price / SalesMarket cap ÷ Revenue | 3.20x | 2.83x | 14.66x | 2.48x | 8.18x |
| Price / BookPrice ÷ Book value/share | 31.26x | 6.29x | — | 6.39x | 3.58x |
| Price / FCFMarket cap ÷ FCF | 27.96x | 15.64x | 29.67x | — | 23.00x |
Profitability & Efficiency
MSCI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
NRC delivers a 57.2% return on equity — every $100 of shareholder capital generates $57 in annual profit, vs $-2 for SATS. SPGI carries lower financial leverage with a 0.39x debt-to-equity ratio, signaling a more conservative balance sheet compared to NRC's 5.65x. On the Piotroski fundamental quality scale (0–9), MSCI scores 8/9 vs SATS's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +57.2% | +30.0% | — | -2.4% | +12.9% |
| ROA (TTM)Return on assets | +6.6% | +10.9% | +24.0% | -49.1% | +7.9% |
| ROICReturn on invested capital | +18.8% | +15.3% | +34.9% | -32.9% | +9.7% |
| ROCEReturn on capital employed | +23.2% | +20.6% | +44.3% | -41.3% | +12.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 8 | 3 | 7 |
| Debt / EquityFinancial leverage | 5.65x | 1.15x | — | 5.33x | 0.39x |
| Net DebtTotal debt minus cash | $75M | $933M | $5.8B | $29.1B | $12.5B |
| Cash & Equiv.Liquid assets | $4M | $475M | $515M | $1.9B | $1.7B |
| Total DebtShort + long-term debt | $79M | $1.4B | $6.3B | $31.0B | $14.2B |
| Interest CoverageEBIT ÷ Interest expense | 3.82x | 12.40x | 7.67x | -9.93x | 22.69x |
Total Returns (Dividends Reinvested)
SATS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SATS five years ago would be worth $47,479 today (with dividends reinvested), compared to $4,800 for NRC. Over the past 12 months, SATS leads with a +540.5% total return vs MORN's -40.5%. The 3-year compound annual growth rate (CAGR) favors SATS at 99.7% vs NRC's -20.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +9.2% | -13.0% | +12.4% | +15.2% | -16.9% |
| 1-Year ReturnPast 12 months | +45.9% | -40.5% | +12.9% | +540.5% | -16.8% |
| 3-Year ReturnCumulative with dividends | -49.7% | -9.6% | +38.3% | +696.0% | +19.5% |
| 5-Year ReturnCumulative with dividends | -52.0% | -18.1% | +43.1% | +374.8% | +18.3% |
| 10-Year ReturnCumulative with dividends | +91.8% | +131.4% | +742.3% | +222.7% | +304.9% |
| CAGR (3Y)Annualised 3-year return | -20.5% | -3.3% | +11.4% | +99.7% | +6.1% |
Risk & Volatility
Evenly matched — MORN and MSCI each lead in 1 of 2 comparable metrics.
Risk & Volatility
MORN is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than SATS's 1.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MSCI currently trades 98.6% from its 52-week high vs MORN's 57.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.80x | 0.41x | 0.56x | 1.72x | 0.49x |
| 52-Week HighHighest price in past year | $22.79 | $316.71 | $640.20 | $147.25 | $579.05 |
| 52-Week LowLowest price in past year | $11.01 | $149.08 | $501.08 | $14.90 | $381.61 |
| % of 52W HighCurrent price vs 52-week peak | +85.7% | +57.5% | +98.6% | +87.7% | +73.2% |
| RSI (14)Momentum oscillator 0–100 | 65.0 | 55.6 | 71.7 | 53.7 | 47.7 |
| Avg Volume (50D)Average daily shares traded | 89K | 487K | 523K | 6.6M | 1.8M |
Analyst Outlook
Evenly matched — NRC and MORN and SPGI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MORN as "Hold", MSCI as "Buy", SATS as "Buy", SPGI as "Buy". Consensus price targets imply 29.9% upside for MORN (target: $237) vs 5.6% for SATS (target: $136). For income investors, NRC offers the higher dividend yield at 2.51% vs SPGI's 0.90%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $236.50 | $688.00 | $136.40 | $548.11 |
| # AnalystsCovering analysts | — | 6 | 27 | 11 | 28 |
| Dividend YieldAnnual dividend ÷ price | +2.5% | +1.0% | +1.1% | — | +0.9% |
| Dividend StreakConsecutive years of raises | 1 | 12 | 11 | 0 | 12 |
| Dividend / ShareAnnual DPS | $0.49 | $1.82 | $7.20 | — | $3.83 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.6% | +11.4% | +5.4% | +0.1% | +4.0% |
MSCI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MORN leads in 1 (Valuation Metrics). 2 tied.
NRC vs MORN vs MSCI vs SATS vs SPGI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NRC or MORN or MSCI or SATS or SPGI a better buy right now?
For growth investors, MSCI Inc.
(MSCI) is the stronger pick with 9. 7% revenue growth year-over-year, versus -5. 2% for EchoStar Corporation (SATS). Morningstar, Inc. (MORN) offers the better valuation at 20. 5x trailing P/E (15. 3x forward), making it the more compelling value choice. Analysts rate MSCI Inc. (MSCI) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NRC or MORN or MSCI or SATS or SPGI?
On trailing P/E, Morningstar, Inc.
(MORN) is the cheapest at 20. 5x versus MSCI Inc. at 40. 6x. On forward P/E, Morningstar, Inc. is actually cheaper at 15. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Morningstar, Inc. wins at 1. 35x versus S&P Global Inc. 's 2. 48x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — NRC or MORN or MSCI or SATS or SPGI?
Over the past 5 years, EchoStar Corporation (SATS) delivered a total return of +374.
8%, compared to -52. 0% for National Research Corporation (NRC). Over 10 years, the gap is even starker: MSCI returned +742. 3% versus NRC's +91. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NRC or MORN or MSCI or SATS or SPGI?
By beta (market sensitivity over 5 years), Morningstar, Inc.
(MORN) is the lower-risk stock at 0. 41β versus EchoStar Corporation's 1. 72β — meaning SATS is approximately 319% more volatile than MORN relative to the S&P 500. On balance sheet safety, S&P Global Inc. (SPGI) carries a lower debt/equity ratio of 39% versus 6% for National Research Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — NRC or MORN or MSCI or SATS or SPGI?
By revenue growth (latest reported year), MSCI Inc.
(MSCI) is pulling ahead at 9. 7% versus -5. 2% for EchoStar Corporation (SATS). On earnings-per-share growth, the picture is similar: S&P Global Inc. grew EPS 18. 7% year-over-year, compared to -113. 6% for EchoStar Corporation. Over a 3-year CAGR, NRC leads at -3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NRC or MORN or MSCI or SATS or SPGI?
MSCI Inc.
(MSCI) is the more profitable company, earning 38. 4% net margin versus -155. 1% for EchoStar Corporation — meaning it keeps 38. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSCI leads at 54. 7% versus -118. 1% for SATS. At the gross margin level — before operating expenses — MSCI leads at 82. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NRC or MORN or MSCI or SATS or SPGI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Morningstar, Inc. (MORN) is the more undervalued stock at a PEG of 1. 35x versus S&P Global Inc. 's 2. 48x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Morningstar, Inc. (MORN) trades at 15. 3x forward P/E versus 32. 2x for MSCI Inc. — 16. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MORN: 29. 9% to $236. 50.
08Which pays a better dividend — NRC or MORN or MSCI or SATS or SPGI?
In this comparison, NRC (2.
5% yield), MSCI (1. 1% yield), MORN (1. 0% yield), SPGI (0. 9% yield) pay a dividend. SATS does not pay a meaningful dividend and should not be held primarily for income.
09Is NRC or MORN or MSCI or SATS or SPGI better for a retirement portfolio?
For long-horizon retirement investors, MSCI Inc.
(MSCI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 56), 1. 1% yield, +742. 3% 10Y return). EchoStar Corporation (SATS) carries a higher beta of 1. 72 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSCI: +742. 3%, SATS: +222. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NRC and MORN and MSCI and SATS and SPGI?
These companies operate in different sectors (NRC (Healthcare) and MORN (Financial Services) and MSCI (Financial Services) and SATS (Technology) and SPGI (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
NRC, MORN, MSCI, SPGI pay a dividend while SATS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.